Eiger BioPharmaceuticals, Inc.
EIGRQ Healthcare Biotechnology
Eiger BioPharmaceuticals, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $15.8 million, up 17.0% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.
Follow EIGRQ
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
75.27 | 53.61 | 39.42 | 25.44 |
Receivables |
3.89 | 3.72 | 1.32 | 1.68 | |
Inventory |
5.34 | 1.10 | 1.11 | 1.56 | |
Total current assets |
96.91 | 70.48 | 54.62 | 37.84 | |
Property, Plant, Equpment (Net) |
0.80 | 0.76 | 0.68 | 0.63 | |
Long-term assets (Other) |
1.07 | 0.79 | 0.14 | 0.36 | |
Total non-current assets |
2.32 | 1.87 | 1.03 | 0.99 | |
Total Assets |
99.23 | 72.36 | 55.65 | 38.83 | |
Accounts Payable |
11.86 | 4.95 | 4.86 | 2.12 | |
Accrued Expenses |
11.71 | 11.45 | 11.46 | 9.97 | |
Current Part of Debt |
0.44 | 0.32 | 0.21 | 41.12 | |
Total current liabilities |
24.00 | 16.71 | 16.52 | 53.28 | |
Long Term Debt (Total) |
39.99 | 40.35 | 40.73 | — | |
Total non-current liabilities |
39.99 | 40.35 | 40.73 | — | |
Total liabilities |
63.99 | 57.06 | 57.26 | 53.28 | |
Additional Paid In Capital |
495.34 | 496.09 | 497.14 | 497.87 | |
Common Stock (Net) |
0.04 | 0.04 | 0.04 | 0.00 | |
Retained Earnings |
(459.98) | (480.67) | (498.70) | (512.16) | |
Common Equity (Total) |
35.24 | 15.30 | (1.60) | (14.46) | |
Shareholders Equity (Total) |
35.24 | 15.30 | (1.60) | (14.46) | |
Shareholders Equity and Liabilities (Total) |
99.23 | 72.36 | 55.65 | 38.83 | |
Shares (Common) |
1.48 | 1.48 | 1.48 | 1.48 | |
Shareholders Equity (Tangible) |
35.24 | 15.30 | (1.60) | (14.46) | |
Net Debt |
(34.85) | (12.94) | 1.52 | 15.68 | |
Total Debt |
40.42 | 40.67 | 40.94 | 41.12 |